UNSPSC 51332706: Clocapramine hydrochloride

This classification denotes an antidepressant agent with the molecular structure C28H37CLN4O.2CLH.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 9NLU6H3LRD chemically known as 1'-(3-(3-chloro-10,11-dihydro-5h-dibenz(b,f)azepin-5-yl)propyl)(1,4'-bipiperidine)-4'-carboxamide dihydrochloride monohydrate, but more commonly known as clocapramine hydrochloride, which bears US NIH Compound Identifier 5282503.

European Medicines Agency schedules Clocapramine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01349MIG. Most nations, for tariff and trade purposes, schedule clocapramine hydrochloride under HS 29333999 and SITC 51574. SMILES: C1CCC2C(C1)CCC3CCC(CC3N2CCCN4CCC(CC4)(C(=O)N)N5CCCCC5)CL.O.CL.CL.

UNSPSC 51332706 Clocapramine hydrochloride is a Commodity code that nominally describes a specific pharmaceutical compound, but the recent state and local solicitation activity under this code shows a substantial mismatch: Seminole County, Florida posted an IFB for naloxone and drug deactivation systems, which are distinct medications and equipment not aligned with the code's stated scope. The county procurement appears to have been tagged with this code in error or through a miscoded taxonomy assignment in the issuing office's system. State and local governments procuring under this code designation should verify that the taxonomy alignment reflects actual pharmaceutical needs, as the recent activity demonstrates inconsistent categorization.

The single recent opportunity posted under UNSPSC 51332706 is Seminole County, Florida IFB 60459723LAS, with a response deadline of July 26, 2023, for annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems delivered quarterly to the Seminole County Community Health Building in Sanford. Vendors must submit bids electronically through the county's e-Procurement Portal, include all shipping and delivery costs, maintain drug-free workplace and E-Verify compliance, and carry workers' compensation, commercial general liability, and professional liability insurance. The contract awards on a fixed-fee basis for an initial two-year term with one-year renewal option and includes a three-month probationary period allowing termination at will. The procurement may receive FEMA funding, bringing additional federal compliance obligations under the Clean Air Act and Federal Water Pollution Control Act. The code shows minimal recent activity, and the mismatch between the stated commodity and the actual solicitation limits its utility for vendors pursuing pharmaceutical supply contracts under this taxonomy.